The review of international clinical guidelines and clinical trial results for the diagnosis of hepatocellular cancer (HCC) for the period 2014–2020

The purpose of this publication is to analyze international clinical guidelines and trial data on the diagnosis hepatocellular carcinoma demonstrate possibilities using MRI with hepatobiliary magnetic resonance contrast agent. As well as an evaluation its diagnostic advantages in comparison other methods such ultrasound, CT extracellular agents. Material methods. Abstracts 331 scientific articles for period 2014–2020 were selected PubMed information analytical system keywords: “hepatocellular carcinoma”, “US”, “CT”, “MRI”, “gadoxetic acid”. Articles about technical aspects cases excluded. After analysis full-text articles, 32 publications selected. Results. presented review has demonstrated agents a wide range application at all stages care patient carcinoma. Conclusion. Despite existing variety diagnosing carcinoma, leading direction area currently gadoxetic acid. high efficiency acid makes it possible increase accuracy imaging choose optimal management each patient.